CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic)

CLPP — Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit

Pathway Diagram

Overview

CLPP — Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit

Pathway Diagram

Overview

Clpp (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit) encodes the proteolytic core of the mitochondrial CLPXP protease complex, essential for mitochondrial protein quality control. CLPP degrades misfolded, oxidized, and regulatory proteins within the mitochondrial matrix. Mutations in CLPP cause Perrault syndrome (hearing loss with ovarian failure), and dysregulated CLPP function has been implicated in aging, neurodegeneration, and cancer. [@clpxp2008]

<div class="infobox infobox-gene"> [@mitochondrial2011]
<table> [@clpp2015]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit</th></tr> [@perrault2016]
<tr><td><strong>Gene Symbol</strong></td><td>CLPP</td></tr> [@clpp2019]
<tr><td><strong>Full Name</strong></td><td>Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit</td></tr> [@mitochondrial2017]
<tr><td><strong>Chromosome</strong></td><td>19p13.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[81792](https://www.ncbi.nlm.nih.gov/gene/81792)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[614922](https://www.omim.org/entry/614922)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000139289</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NZJ5](https://www.uniprot.org/uniprot/Q9NZJ5)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Mitochondrial protease (CLP family)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Perrault Syndrome, Hearing Loss, Ovarian Failure</td></tr>
</table>
</div>

Molecular Biology and Biochemistry

Protein Structure

CLPP is a 473-amino acid mitochondrial matrix protease:

• Heptad repeat regions: Oligomerization domains
• Protease active sites: Ser-His-Asp catalytic triad
• N-terminal signal peptide: Mitochondrial targeting (cleaved)
• C-terminal extension: Regulatory function

The CLPXP Complex

| Component | Function |
|-----------|----------|
| CLPP | Proteolytic core, protein degradation |
| CLPX | AAA+ ATPase, unfoldase, substrate recognition |
| CLPA | Adaptor protein, regulation |

Substrate Recognition

CLPXP degrades substrates with specific degrons:

• Oxidized proteins (carbonylation marks)
• Misfolded proteins
• Regulatory peptides (e.g., mitochondrial transit peptides)
• Specific mitochondrial proteins (e.g., EFG, tRNA synthetases)

Expression Pattern

Tissue Distribution

CLPP is ubiquitously expressed with highest levels in:

• Heart and skeletal muscle (high mitochondrial content)
• Liver and kidney
• Brain ([neurons](/entities/neurons) with high energy demands)
• Ovaries and inner ear (Perrault syndrome tissues)

Cellular Localization

• Mitochondria: Matrix compartment exclusively
• Submitochondrial: Forms CLPXP complexes in matrix

Physiological Functions

Mitochondrial Protein Quality Control

CLPP maintains mitochondrial proteostasis:

Mitochondrial Dynamics

CLPP regulates:

• Mitochondrial biogenesis
• Mitophagy (selective autophagy)
• Mitochondrial DNA maintenance
• Iron-sulfur cluster assembly

Cellular Stress Response

Under stress conditions:

• Oxidative stress: Increased CLPP activity
• Heat shock: CLPP-mediated protein quality control
• Nutrient deprivation: Metabolic adaptation
• Hypoxia: Adaptive responses

Disease Associations

Perrault Syndrome

Clinical Features:

| Feature | Description |
|---------|-------------|
| Sensorineural hearing loss | Progressive, bilateral |
| Ovarian failure | Primary or secondary amenorrhea |
| Neurologic features | Ataxia, neuropathy (some cases) |
| Variable expressivity | Even within families |

Genetics:

• Autosomal recessive inheritance
• Multiple causative genes (CLPP, HARS2, TWNK)
• Missense and nonsense mutations

• Mitochondrial dysfunction in hair cells
• Impaired protein quality control
• Enhanced [apoptosis](/entities/apoptosis) in vulnerable cells

Neurodegeneration

CLPP dysfunction implicated in:

• [Alzheimer's disease](/diseases/alzheimers-disease): Mitochondrial CLPP activity altered
• [Parkinson's disease](/diseases/parkinsons-disease): PINK1/Parkin-CLPP interactions
• Amyotrophic lateral sclerosis: Mitochondrial proteostasis failure
• Aging: Declining CLPP function with age

Cancer

• Tumor suppressive role: CLPP loss enhances tumorigenesis
• Therapeutic targeting: CLPP inhibitors in cancer therapy
• Metabolism: Altered mitochondrial function in cancer

Mechanisms of Pathogenesis

Mitochondrial Dysfunction

CLPP deficiency leads to:

• Accumulation of misfolded proteins
• Respiratory chain impairment
• Reduced ATP production
• Increased [ROS](/entities/reactive-oxygen-species) production

Apoptosis

• Enhanced sensitivity to apoptotic stimuli
• Cytochrome c release
• Caspase activation
• Cell death in vulnerable tissues

Inflammation

• Mitochondrial DAMPs release
• Inflammasome activation
• Chronic inflammation

Therapeutic Implications

Perrault Syndrome

• Hearing aids: Symptomatic treatment
• Hormone replacement: For ovarian failure
• Gene therapy: Future therapeutic approach

Neurodegeneration

• CLPP activators: Enhance mitochondrial QC
• Antioxidants: Reduce oxidative stress
• Mitochondrial protectants: Preserve function

Cancer

• CLPP inhibitors: Synthetic lethality in cancer
• Combination therapy: With DNA-damaging agents

Research Methods

Experimental Models

• Knockout mice: Clpp-/- models
• Zebrafish: Morpholino knockdown
• Patient iPSCs: Sensory hair cells

Detection Techniques

• Western blotting: Expression analysis
• Protease assays: Activity measurement
• Mitochondrial function: Respirometry
• Live cell imaging: Mitochondrial morphology

Summary

CLPP is the proteolytic core of the mitochondrial CLPXP protease complex, essential for mitochondrial protein quality control. Mutations cause Perrault syndrome with hearing loss and ovarian failure, while dysregulated CLPP contributes to neurodegeneration and cancer. Understanding CLPP biology provides insights into mitochondrial proteostasis and potential therapeutic targets.

Overview

Clpp (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Clpp (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene: CLPP](https://www.ncbi.nlm.nih.gov/gene/10888)
• [UniProt: CLPP](https://www.uniprot.org/uniprot/Q6JVM9)
• [GeneCards: CLPP](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLPP)

References

See Also

• [Aging and Rejuvenation Knowledge Gaps](/wiki/gaps-aging) — associated_with
• [Aging and Rejuvenation Knowledge Gaps](/wiki/gaps-aging) — therapeutic_target
• [Gap Analysis & Research Strategy](/wiki/gaps-gap-analysis) — associated_with
• [Gap Analysis & Research Strategy](/wiki/gaps-gap-analysis) — transports
• [ATM Gene](/wiki/genes-atm) — associated_with

Pathway Diagram

The following diagram shows the key molecular relationships involving CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic) discovered through SciDEX knowledge graph analysis: